During the past decade, Hospital Seberang Jaya conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Seberang Jaya" #1 sponsor was "Pfizer" with 1 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored, "Sinovac Research and Development Co., Ltd." with 1 trials sponsored, "The George Institute" with 1 trials sponsored and "Venn Biosciences Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Seberang Jaya" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Centre Hospitalier Régional Universitaire de Nancy" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator and "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Seberang Jaya" are "Adnexal Mass" (1 trials), "COVID-19" (1 trials), "Cardiovascular Disease" (1 trials), "Chronic Kidney Diseases" (1 trials) and "Chronic Low Back Pain With a Neuropathic Component" (1 trials). Many other conditions were trialed in "Hospital Seberang Jaya" in a lesser frequency.

Most popular intervention types in "Hospital Seberang Jaya" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATM-AVI" (1 trials), "COL" (1 trials), "Controlled vaccine" (1 trials), "Inactivated COVID-19 Vaccine" (1 trials) and "MER" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Seberang Jaya" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Seberang Jaya". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Seberang Jaya, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Seberang Jaya, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".